Stephan Kramer, graduate of the Full-Time MBA, started his career in finance. After a professional reorientation, he founded his own company in 2019 in the pharmaceutical industry. HEYDAY is an innovative company that is decisively shaping the future of the medical cannabis market in Germany and could thus also be groundbreaking for other countries globally.

HEYDAY AG was founded to take a strong position in the currently emerging German and international market for cannabis. In the fall of 2020, the company will operationally enter the medical cannabis market. The shareholders and network of HEYDAY AG have extensive and intensive experience in building and managing companies, strategic political communication and positioning in strictly regulated market environments. Investors include high-profile entrepreneurs, private and institutional investors, lawyers and pharmaceutical experts.